Free Trial

Arcadia Biosciences (RKDA) SEC Filings & 10K Form

Arcadia Biosciences logo
$3.86 -0.33 (-7.88%)
(As of 11/14/2024 ET)

Recent Arcadia Biosciences SEC Filings

DateFilerForm TypeView
11/12/2024
4:00 PM
Arcadia Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/23/2024
10:56 AM
Arcadia Biosciences (Filer)
Form 8-K/A
08/21/2024
6:32 PM
Arcadia Biosciences (Issuer)
WALLER GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
6:41 PM
Arcadia Biosciences (Issuer)
Yoder Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
6:20 PM
Arcadia Biosciences (Issuer)
Carosella Deborah D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
6:26 PM
Arcadia Biosciences (Issuer)
Murray Lilian Shackelford (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
6:06 PM
Arcadia Biosciences (Issuer)
Comcowich Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
6:14 PM
Arcadia Biosciences (Issuer)
Bolles Albert D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:26 PM
Arcadia Biosciences (Issuer)
Kawakami Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:09 PM
Arcadia Biosciences (Issuer)
Schaefer Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
7:11 PM
Arcadia Biosciences (Issuer)
Kawakami Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
7:05 PM
Arcadia Biosciences (Issuer)
Schaefer Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:16 PM
Arcadia Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
11:07 AM
Arcadia Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:22 PM
Arcadia Biosciences (Issuer)
Kawakami Mark (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
3:11 PM
Arcadia Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
3:33 PM
Arcadia Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
2:15 PM
Arcadia Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
1:13 PM
Arcadia Biosciences (Filer)
Form DEF 14A
05/16/2024
1:16 PM
Arcadia Biosciences (Filer)
Form DEFA14A
05/13/2024
2:31 PM
Arcadia Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
3:08 PM
Arcadia Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
1:07 PM
Arcadia Biosciences (Filer)
Form 10-K/A
03/28/2024
4:20 PM
Arcadia Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/03/2024
11:26 AM
Arcadia Biosciences (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RKDA) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners